Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open, Multicentre, Randomised, Parallel Group Pilot-Study to Compare Safety and Efficacy of Discontinuation of Mycophenolate Mofetil From a Tacrolimus/MMF/Steroid Triple Regimen Following Kidney Transplantation

NCT00693381 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00693381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00693381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open, Multicentre, Randomised, Parallel Group Pilot-Study to Compare Safety and Efficacy of Discontinuation of Mycophenolate Mofetil From a Tacrolimus/MMF/Steroid Triple Regimen Following Kidney Transplantation
Lead sponsor
Astellas Pharma Inc
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2003
Completion date
August 31, 2004
Enrollment
152 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplantation